Vimarsana
Biggest News Aggregation in the World

Mel Management News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mel Management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mel Management Today - Breaking & Trending Today

Celyad Oncology receives approximately EUR 9.8m in private placement commitments from historical shareholders - Vimarsana News

Celyad Oncology receives approximately EUR 9.8m in private placement commitments from historical shareholders

Published: August 24, 2023

MONT-SAINT-GUIBERT, Belgium, Aug. 24, 2023 -- regulated information / inside information - Celyad Oncology SA today announced that it has obtained commitments from an affiliate of Fortress...

Source: marketscreener.com
Related Topics:
United StatesMont Saint GuibertWaals GewestNew YorkCaroline LonezDavid GeorgesGeorges RawadiMichel LussierExchange CommissionBusiness DevelopmentBelgian Code Of CompaniesFortress Investment GroupWrd CommunicationsMel ManagementRoyal DecreeBelgian CodeUnited States Securities ActSecurities ActPrivate Securities Litigation Reform ActCelyad OncologyAnnual Report
Celyad Oncology receives approximately EUR 9.8m in private placement commitments from ... - Vimarsana News

Celyad Oncology receives approximately EUR 9.8m in private placement commitments from ...

Published: August 24, 2023

MONT-SAINT-GUIBERT, Belgium, Aug. 24, 2023 (GLOBE NEWSWIRE) -- regulated information / inside information - Celyad Oncology SA (“Celyad” or the “Company”) today announced that it has obtained commitments from an

Source: kentuckytoday.com
Related Topics:
Mont Saint GuibertWaals GewestNew YorkUnited StatesGeorges RawadiDavid GeorgesMichel LussierCaroline LonezBelgian Code Of CompaniesFortress Investment GroupWrd CommunicationsBusiness DevelopmentExchange CommissionMel ManagementRoyal DecreeBelgian CodeUnited States Securities ActSecurities ActPrivate Securities Litigation Reform ActCelyad OncologyAnnual Report